Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

87
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
87
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

78
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
78
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

107
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
107
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

62
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
62
Dialysis01:27

Dialysis

505
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
505
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

52
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
52

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Barriers to Kidney Transplantation in the United States.

Journal of the American Society of Nephrology : JASN·2026
Same author

Largest Year-on-Year Decline in Deceased Donation in United States History.

Clinical transplantation·2026
Same author

Newly Designed Expedited Allocation Pathways Cannot Be Expected to Rely on Data That Does Not Currently Exist.

Kidney360·2026
Same author

Evaluation and Counseling of Living Kidney Donor Candidates.

Journal of the American Society of Nephrology : JASN·2026
Same author

Insights From Black Living Kidney Donors: An Interview Study on APOL1 Genetic Testing Experiences.

Clinical transplantation·2026
Same author

Pediatric Kidney Transplant Outcomes After Kidney Donor Profile Index-Based Organ Prioritization.

Pediatric transplantation·2026
Same journal

Impact of APOL1-Associated Pregnancy Complications on Kidney Disease Phenotypes in a HIV-Associated Nephropathy Mouse Model.

Kidney360·2026
Same journal

Risk Prediction of 2-Year Incident Cognitive Impairment in Maintenance Hemodialysis Patients: A Multicenter Prospective Cohort Study.

Kidney360·2026
Same journal

Anti-Glomerular Basement Membrane Nephritis Post-Renal Transplant in Alport Syndrome Patients.

Kidney360·2026
Same journal

Non-Classical Monocyte Expansion Is Independently Associated with Anemia Severity in Patients with ESKD: The Immunity in End-Stage Renal Disease Cohort-Study.

Kidney360·2026
Same journal

Adult-Onset Hereditary Thrombotic Thrombocytopenic Purpura Presenting as Kidney Failure: A Heterozygous ADAMTS13 Variant and Possible Modifying Polymorphisms.

Kidney360·2026
Same journal

Impact of Prior Adverse Pregnancy Outcome on Kidney Structure and Function in Kidney Donors.

Kidney360·2026
See all related articles

Related Experiment Video

Updated: Sep 19, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

872

Financial Toxicity in ESKD.

Lindsey M Maclay1,2, Kyle Woodward1,2, Natalie Strohmayer1,2

  • 1Division of Nephrology, Department of Medicine, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.

Kidney360
|June 5, 2025
PubMed
Summary
This summary is machine-generated.

Kidney failure patients face significant financial toxicity, with 71% experiencing it. Many report reduced employment and income, especially those on dialysis, highlighting treatment impacts on financial well-being.

Keywords:
ESKDdialysiseconomic impacthealth policykidney failureminority health and disparitiesquality of lifesocial determinants of healthtransplantation

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.5K

Related Experiment Videos

Last Updated: Sep 19, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

872
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.5K

Area of Science:

  • Nephrology
  • Health Economics
  • Public Health

Background:

  • Kidney failure treatments are demanding and time-intensive.
  • These treatments can interfere with employability and incur indirect costs.
  • Financial toxicity is a significant concern for patients with kidney failure.

Purpose of the Study:

  • To characterize the prevalence of financial toxicity in kidney failure patients.
  • To identify risk factors associated with financial toxicity.
  • To explore the relationship between kidney replacement therapy modality and financial burden.

Main Methods:

  • Cross-sectional survey study of 112 kidney failure patients.
  • Assessment of financial toxicity using the validated Cost Tool (CoST) and self-reported financial changes.
  • Comparison of financial toxicity by kidney replacement therapy modality (dialysis, transplant).

Main Results:

  • 71% of participants experienced at least mild financial toxicity (median CoST score of 17).
  • Financial toxicity was more prevalent in non-White patients and those receiving dialysis.
  • Over 60% reported reduced employment and 57% reported reduced income, particularly among dialysis patients.

Conclusions:

  • Adults with kidney failure experience substantial financial toxicity.
  • Negative changes in employment and income are common and linked to kidney failure.
  • Treatment modality, such as dialysis, significantly impacts the financial burdens faced by patients.